© 1997 American Heart Association, Inc.
Articles |
Relation of Plaque Lipid Composition and Morphology to the Stability of Human Aortic Plaques
Correspondence to C.V. Felton, PhD, Wynn Department of Metabolic Medicine, 21 Wellington Rd, St John's Wood, London NW8 9SQ, United Kingdom.
Abstract The propensity of atherosclerotic plaques to disrupt may be influenced by their lipid content and the distribution of these lipids within the plaque. To investigate this, we analyzed the morphological and lipid profiles of 668 human aortic plaques from 30 males who had died of ischemic heart disease. Plaques were classified as disrupted or as intact types A or B, the latter distinction being based on the absence or presence, respectively, of disrupted plaques within the same aorta. Disrupted plaques have a greater content of lipid (P<.001) and macrophages (P<.001) as well as a thinner cap (P<.001) than intact plaques. Lipid concentrations are positively associated with macrophage accumulation in all plaque types and are negatively associated with minimum cap thickness at the edge of disrupted plaques (P<.05). Free cholesterol concentration is inversely associated with minimum cap thickness at the center of type B plaques only (P<.05). At the center of intact type A and B and disrupted plaques, the free-to-esterified cholesterol ratios were 0.9 (range, 0.0 to 2.7), 0.8 (0.0 to 3.9), and 1.6 (0.2 to 4.0), respectively. Esterified cholesterol concentrations were higher at the center of type B plaques, and those of free cholesterol were higher at the center of disrupted plaques. At the edge of disrupted plaques, the free-to-esterified cholesterol ratio was 0.5 (0.0 to 2.7) because of the accumulation of esterified cholesterol. Concentrations of all fatty acids were increased at the edge of disrupted plaques compared with the center, but as a proportion of total fatty acids, omega6-polyunsaturated fatty acids (PUFAs) were lower (44% versus 46%, P<.01), possibly reflecting oxidation of PUFAs. These data demonstrate differences in lipid composition and intraplaque lipid distribution between intact and disrupted plaques. At the edge of advanced plaques, increased esterified lipid concentrations, inversely associated with cap thickness, may reflect macrophage activity and a predisposition to rupture.
Key Words: plaque disruption • lipids • fatty acids • atherosclerosis • thrombosis
This article has been cited by other articles:
 |
|
 |
|
  V. Paul, H. H. D. Meyer, K. Leidl, S. Soumian, and C. Albrecht A novel enzyme immunoassay specific for ABCA1 protein quantification in human tissues and cells J. Lipid Res., October 1, 2008; 49(10): 2259 - 2267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Tziakas, G. K. Chalikias, I. K. Tentes, D. Stakos, S. V. Chatzikyriakou, K. Mitrousi, A. X. Kortsaris, J. C. Kaski, and H. Boudoulas Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome Eur. Heart J., September 2, 2008; (2008) ehn382v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Brown and A. J. Taylor Does ENHANCE Diminish Confidence in Lowering LDL or in Ezetimibe? N. Engl. J. Med., April 3, 2008; 358(14): 1504 - 1507. [Full Text] [PDF]
|
|
|
|
 |
|
 O. C. Raffel, G. J. Tearney, D. D. Gauthier, E. F. Halpern, B. E. Bouma, and I.-K. Jang Relationship Between a Systemic Inflammatory Marker, Plaque Inflammation, and Plaque Characteristics Determined by Intravascular Optical Coherence Tomography Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1820 - 1827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Arbustini Total Erythrocyte Membrane Cholesterol: An Innocent New Marker or an Active Player in Acute Coronary Syndromes? J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2090 - 2092. [Full Text] [PDF]
|
|
|
|
|
|
D. N. Tziakas, J. C. Kaski, G. K. Chalikias, C. Romero, S. Fredericks, I. K. Tentes, A. X. Kortsaris, D. I. Hatseras, and D. W. Holt Total Cholesterol Content of Erythrocyte Membranes Is Increased in Patients With Acute Coronary Syndrome: A New Marker of Clinical Instability? J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2081 - 2089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. L. Ruberg, J. Viereck, A. Phinikaridou, Y. Qiao, J. Loscalzo, and J. A. Hamilton Identification of cholesteryl esters in human carotid atherosclerosis by ex vivo image-guided proton MRS J. Lipid Res., February 1, 2006; 47(2): 310 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Rodriguez-Granillo, H. M. Garcia-Garcia, E. P. Mc Fadden, M. Valgimigli, J. Aoki, P. de Feyter, and P. W. Serruys In Vivo Intravascular Ultrasound-Derived Thin-Cap Fibroatheroma Detection Using Ultrasound Radiofrequency Data Analysis J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2038 - 2042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Krams, S. Verheye, L. C.A. van Damme, D. Tempel, B. M. Gourabi, E. Boersma, M. M. Kockx, M. W.M. Knaapen, C. Strijder, G. van Langenhove, et al. In vivo temperature heterogeneity is associated with plaque regions of increased MMP-9 activity Eur. Heart J., October 2, 2005; 26(20): 2200 - 2205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Virmani, F. D. Kolodgie, A. P. Burke, A. V. Finn, H. K. Gold, T. N. Tulenko, S. P. Wrenn, and J. Narula Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2054 - 2061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Albrecht, S. Soumian, J.S. Amey, A. Sardini, C.F. Higgins, A.H. Davies, and R.G.J. Gibbs ABCA1 Expression in Carotid Atherosclerotic Plaques Stroke, December 1, 2004; 35(12): 2801 - 2806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bro, F. Moeller, C. B. Andersen, K. Olgaard, and L. B. Nielsen Increased Expression of Adhesion Molecules in Uremic Atherosclerosis in Apolipoprotein-E-Deficient Mice J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1495 - 1503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Mason, M. F. Walter, and R. F. Jacob Effects of HMG-CoA Reductase Inhibitors on Endothelial Function: Role of Microdomains and Oxidative Stress Circulation, June 1, 2004; 109(21_suppl_1): II-34 - II-41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. D. Kolodgie, H. K. Gold, A. P. Burke, D. R. Fowler, H. S. Kruth, D. K. Weber, A. Farb, L.J. Guerrero, M. Hayase, R. Kutys, et al. Intraplaque Hemorrhage and Progression of Coronary Atheroma N. Engl. J. Med., December 11, 2003; 349(24): 2316 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S W E van de Poll, K Kastelijn, T C B. Schut, C Strijder, G Pasterkamp, G J Puppels, and A van der Laarse On-line detection of cholesterol and calcification by catheter based Raman spectroscopy in human atherosclerotic plaque ex vivo Heart, September 1, 2003; 89(9): 1078 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Burke, R. Virmani, Z. Galis, C. C. Haudenschild, and J. E. Muller Task force #2--what is the pathologic basis for new atherosclerosis imaging techniques? J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1874 - 1886. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Qu, T. T. Le, S. P. Azen, M. Xiang, N. D. Wong, T. M. Doherty, and R. C. Detrano Value of Coronary Artery Calcium Scanning by Computed Tomography for Predicting Coronary Heart Disease in Diabetic Subjects Diabetes Care, March 1, 2003; 26(3): 905 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Shah Mechanisms of plaque vulnerability and rupture J. Am. Coll. Cardiol., February 19, 2003; 41(4_Suppl_S): 15S - 22S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Forrester Prevention of Plaque Rupture: A New Paradigm of Therapy Ann Intern Med, November 19, 2002; 137(10): 823 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lutgens, M. Gijbels, M. Smook, P. Heeringa, P. Gotwals, V. E. Koteliansky, and M. J.A.P. Daemen Transforming Growth Factor-{beta} Mediates Balance Between Inflammation and Fibrosis During Plaque Progression Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 975 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kamido, H. Eguchi, H. Ikeda, T. Imaizumi, K. Yamana, K. Hartvigsen, A. Ravandi, and A. Kuksis Core aldehydes of alkyl glycerophosphocholines in atheroma induce platelet aggregation and inhibit endothelium-dependent arterial relaxation J. Lipid Res., January 1, 2002; 43(1): 158 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Marcu, M. C. Fishbein, J.-M. I. Maarek, and W. S. Grundfest Discrimination of Human Coronary Artery Atherosclerotic Lipid-Rich Lesions by Time-Resolved Laser-Induced Fluorescence Spectroscopy Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1244 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Bentzon, E. Skovenborg, C. Hansen, J. Moller, N. S.-C. de Gaulejac, J. Proch, and E. Falk Red Wine Does Not Reduce Mature Atherosclerosis in Apolipoprotein E-Deficient Mice Circulation, March 27, 2001; 103(12): 1681 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Rauch, J. I. Osende, V. Fuster, J. J. Badimon, Z. Fayad, and J. H. Chesebro Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences Ann Intern Med, February 6, 2001; 134(3): 224 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tsimikas, W. Palinski, and J. L. Witztum Circulating Autoantibodies to Oxidized LDL Correlate With Arterial Accumulation and Depletion of Oxidized LDL in LDL Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 95 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Peng, W. Guo, J. D. Morrisett, M. T. Johnstone, and J. A. Hamilton Quantification of Cholesteryl Esters in Human and Rabbit Atherosclerotic Plaques by Magic-Angle Spinning 13C-NMR Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2682 - 2688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Young, G. K. Sukhova, D. Foster, W. Kisiel, P. Libby, and U. Schonbeck The Serpin Proteinase Inhibitor 9 Is an Endogenous Inhibitor of Interleukin 1{beta}-converting Enzyme (Caspase-1) Activity in Human Vascular Smooth Muscle Cells J. Exp. Med., May 1, 2000; 191(9): 1535 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tsimikas, B. P. Shortal, J. L. Witztum, and W. Palinski In Vivo Uptake of Radiolabeled MDA2, an Oxidation-Specific Monoclonal Antibody, Provides an Accurate Measure of Atherosclerotic Lesions Rich in Oxidized LDL and Is Highly Sensitive to Their Regression Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 689 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kellner-Weibel, P. G. Yancey, W. G. Jerome, T. Walser, R. P. Mason, M. C. Phillips, and G. H. Rothblat Crystallization of Free Cholesterol in Model Macrophage Foam Cells Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1891 - 1898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Burke, A. Farb, G. T. Malcom, Y.-h. Liang, J. E. Smialek, and R. Virmani Plaque Rupture and Sudden Death Related to Exertion in Men With Coronary Artery Disease JAMA, March 10, 1999; 281(10): 921 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Libby The interface of atherosclerosis and thrombosis: basic mechanisms Vascular Medicine, August 1, 1998; 3(3): 225 - 229. [Abstract] [PDF]
|
|
|
|
|
|
G. Kellner-Weibel, W. G. Jerome, D. M. Small, G. J. Warner, J. K. Stoltenborg, M. A. Kearney, M. H. Corjay, M. C. Phillips, and G. H. Rothblat Effects of Intracellular Free Cholesterol Accumulation on Macrophage Viability : A Model for Foam Cell Death Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 423 - 431. [Abstract] [Full Text] [PDF]
|
|